Rhinocerebral mucormycosis. Report of four cases;Mucormicosis rinocerebral. Comunicación de 4 casos

Revista Medica de Chile

Volumn 127, Issue 6, 1999, Pages 712-718

  Bravo, M Mauricio ^a   Ferrer, D Sergio ^a   Etchard, M Martín ^a   Trujillo, V Sergio ^a  

^a HOSPITAL MILITAR DE SANTIAGO   (Chile)

Author keywords

Amphotericin; Diabetes mellitus; Mucormycosis

Indexed keywords

AGED; ARTICLE; BRAIN DISEASE; CASE REPORT; FEMALE; HUMAN; MALE; MIDDLE AGED; MUCORMYCOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOSE DISEASE; PATHOLOGY;

AGED; BRAIN DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCORMYCOSIS; NOSE DISEASES;

EID: 0033145211     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. HAMMER GS, BOTTONE EJ, HIRSCHMANN SZ. Mucormycosis in transplant recipient. Am J Clin Pathol, 1975, 64: 389-98.
2. MANDELL, DOUGLAS AND BENNETT'S. Principles and Practice of Infections Diseases, Fourth Edition 1995; 2311-7.
3. PARFKEY NA. Improved diagnosis and prognosis of Mucormycosis: A clinico-pathologic, study of 33 cases. Medicine, 1986, 65: 113-23.
4. NUSSBAUM ES, HALL WA. Rinocerebral Mucormycosis: Changing patterns of disease. Surg Neurol, 1994, 41: 152-6.
5. YOHAI ROBERT MD, BULLOCK MD, ANDY A, AZIZ MD, RONALD MARKERT. Survival factors in Rhinoorbitalcerebral mucormycosis. Survey Ophthalmol, 1994; 39: 3-22
6. COX J, CORONA S, DONOSO S. Mucormicosis orbitaria cerebral en 2 pacientes diabéticos. Rev Med Chil, 1985, 113: 341-4.
7. ODDÓ D, LOBOS T. Micosis Inhabituales en Chile. Comunicación de 10 casos. Rev Méd Chil, 1988, 116: 1135-44.
8. O'BRIEN TJ, MC KELVIE P. Rhinocerebral Mucormycosis presenting as periorbital cellulitis with blindness: report of 2 cases. Clin Exp Neurol (Australia), 1994; 31: 68-78.
9. OSTROW TD, HUDGINS PA. Magnetic Resonance Imaging of Intracraneal fungal infections, Top Magn Reson Imaging, 1994.
10. PILLSBURY HC, FISCHER ND. Rhinocerebral Mucormycosis. Arch Otolaryngol 1977, 103: 600-4.
11. MEYER RD, ARMSTRONG D. Mucormycosis Changing status. Crit Rev Clin Lab Sci 1973 4: 421-51
12. FERRY AP. Cerebral Mucormycosis: Ocular findings and review of the literature. Surv Ophthalmol. 1961, 6: 124.
13. ARTIS WIM, FOUNTAIN JA, DELCHER HK, AND JONES HE. A mechanism of suceptibility to Mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 1982; 31: 1109-14.
14. ESPINOZA CG, HALKIAS DG. Pulmonary Mucormycosis as a complication of chronic salicylate poisoning. Am J Clin Pathol 1983, 80: 508-11.
15. CHINN RY, DIAMOND RD. Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophila and effects of hyperglicemia and ketoacidosis. Infect Human 1982; 38: 1123-9.
16. WEINBERG ED. Iron and Infection. Microbiolg Rev 1978, 42: 45-66.
17. CORBEL MJ, EADES SM. Factors determining the suceptibility of mice to experimental phycomycosis. J Med Microbiol 1975; 8: 551-64.
18. SHELDON WH, AND BAUER H. Activation of quiescent mucormycosis granulomata in rabbits by induction of acute diabetic. J Exp Med: 1958,108: 171-79.